Sai Life Sciences to host investors at Jefferies forum on Sep 18

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • Sai Life Sciences hosts officials at Jefferies 5th India Forum
  • Meeting scheduled for September 18, 2026, in Gurugram
  • Sessions include group and one-on-one formats
  • Only publicly available information will be discussed
powered bylight_fuzz_icon
50083056

*this image is generated using AI for illustrative purposes only.

Sai Life Sciences will host company officials at the Jefferies 5th India Forum in Gurugram on September 18, 2026. The event runs from 9:00 am to 6:00 pm IST.

The pharma firm disclosed the schedule under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. Discussions will be conducted in person through group and one-on-one sessions.

Date / Time Organisation Mode Venue
Sep 18, 2026 (9 am - 6 pm) Jefferies 5th India Forum Group / One-on-One Gurugram

Company representatives will base all discussions on publicly available information. No unpublished price-sensitive information will be shared during the meetings.

The schedule remains subject to change due to exigencies involving participants or the company. Investors and analysts may approach Sai Life Sciences for clarifications regarding the discussions after the event.

Historical Stock Returns for Sai Life Sciences

1 Day5 Days1 Month6 Months1 Year5 Years
+0.60%+6.46%+18.82%+59.01%+86.86%0.0%

How might the insights shared at the Jefferies 5th India Forum influence Sai Life Sciences' valuation among institutional investors?

What specific strategic initiatives or pipeline updates is the company likely to highlight during these one-on-one sessions with analysts?

Could participation in this forum signal an upcoming capital raising activity or significant partnership announcement for Sai Life Sciences?

Sai Life Sciences to host investor meeting at Morgan Stanley conference

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights
  • Sai Life Sciences to host investors at Morgan Stanley conference on September 14, 2026
  • Meetings will be held in New York from 9:00 am to 6:00 pm EST
  • Discussions limited to publicly available information only
  • Schedule subject to change based on participant exigencies
powered bylight_fuzz_icon
50082179

*this image is generated using AI for illustrative purposes only.

Sai Life Sciences Limited will host analysts and institutional investors at the Morgan Stanley Annual Global Healthcare Conference on September 14, 2026, in New York.

The company disclosed the schedule pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. Officials from Sai Life Sciences are scheduled to participate in group and one-on-one meetings throughout the day.

Meeting Details

The engagement is part of the 24th Annual Global Healthcare Conference organized by Morgan Stanley. The meetings will be conducted in person and cover both group sessions and individual discussions with investors and analysts.

Date / Time Organisation Type / Mode Venue
September 14, 2026, 9:00 am to 6:00 pm (EST) Morgan Stanley - 24th Annual Global Healthcare Conference Group / One-on-One (In-person) New York

Regulatory Disclosures

The company stated that all discussions during the meeting will be based on publicly available information. No unpublished price-sensitive information will be shared. The schedule is subject to change due to exigencies involving participants or the company.

Investors and analysts may approach the company for clarifications regarding the discussions after the meeting. The information is also available on the company’s website.

Historical Stock Returns for Sai Life Sciences

1 Day5 Days1 Month6 Months1 Year5 Years
+0.60%+6.46%+18.82%+59.01%+86.86%0.0%

How might the strategic updates shared by Sai Life Sciences at this conference influence its valuation relative to other CDMO peers in the global healthcare sector?

What specific pipeline developments or capacity expansion plans are analysts likely to focus on during the one-on-one sessions?

Could the outcomes of these investor meetings signal any upcoming M&A activity or partnership announcements for Sai Life Sciences in late 2026?

More News on Sai Life Sciences

1 Year Returns:+86.86%